NURS 6521N Advanced Pharmacology Actual Fall 2024 NURS 6521N Midterm Exam | Actual Review Questions and Verified Correct Answers | 100% Pass | Graded A+ | Guaranteed Success |

Walden University
Chamberlain University

NUR 546
NURS 6521NPsychopharmacology for the
Advanced Pharmacology
Psychiatric- Mental Health Nurse
NURS 6521N ExamPractitioner
NUR 546 Final
Course TitleTitle
Course and Number: NUR 546 Psychopharmacology
and Number: for the
NURS 6521N Advanced
Psychiatric-Mental
Pharmacology Health Nurse Practitioner
Exam Title: NURS 6521N Midterm and Final
Exam Title: NUR 546 Final
Exam Date: Midterm and Final Exam 2024- 2025
Instructor: [Insert
Exam Date: Final ExamInstructor’s
2024- 2025Name]
Student Name: [Insert Student’s Name]
Student
Instructor:ID:
[Insert Instructor’s
[Insert Student Name]
ID]

Student Name: [Insert Student’s Name]

Midterm
Student ID: andID]Final
[Insert Student Examination
180 minutes
Final Examination
Instructions: 180 minutes

1. Read each question carefully.
Instructions:
2. Answer all questions.
1. Read each question carefully.
3.2.Use the provided
Answer answer sheet to mark your responses.
all questions.
4.3.Ensure
Use theall answers
provided are final
answer sheetbefore
to marksubmitting the exam.
your responses.
4. Ensure all answers are final before submitting the exam.

Good
Good Luck!Luck!

, NURS 6521N Advanced Pharmacology Actual Fall
2024 NURS 6521N Midterm Exam | Actual Review
Questions and Verified Correct Answers | 100% Pass |
Graded A+ | Guaranteed Success |

This Is the Actual Fall 2024 Week 6 Midterm
Exam I Took the Test and Scored 89/100. I
have reviewed the Exam and Provided the
Correct Answers




NURS 6521N Advanced Pharmacology Midterm Exam


Question 1

SGLT2 inhibitors may have a role in treating which of the
following conditions?

 A. Thyroid disorders
 B. Pulmonary hypertension
 C. Renal failure
 D. Hepatic dysfunction
 E. Cardiac arrhythmias

Correct Answer: C. Renal failure

,Question 2

Which of the following phases is most concerned with drug
absorption and metabolism?

 A. Distribution phase
 B. Pharmacokinetic phase
 C. Storage phase
 D. Pharmaceutical phase
 E. Pharmacodynamic phase

Correct Answer: B. Pharmacokinetic phase


Question 3

Why is pyridostigmine useful in the symptomatic treatment of
myasthenia gravis?

 A. Pyridostigmine inhibits acetylcholinesterase, increasing
acetylcholine availability.
 B. Pyridostigmine increases the degradation of
acetylcholine at the neuromuscular junction.
 C. Pyridostigmine acts as an immunosuppressant,
reducing antibody production against acetylcholine
receptors.
 D. Pyridostigmine blocks calcium channels in the
presynaptic neuron.
 E. Pyridostigmine directly stimulates acetylcholine
receptors on the muscle cell surface.

Correct Answer: A. Pyridostigmine inhibits
acetylcholinesterase, increasing acetylcholine availability.


Question 4

, What is the first-pass effect?

 A. Release of a drug's active ingredient from its
formulation
 B. Drug metabolism in the liver before reaching systemic
circulation
 C. Immediate drug effect upon first administration
 D. Initial drug distribution and plasma protein binding
 E. Complete drug elimination after first use

Correct Answer: B. Drug metabolism in the liver before
reaching systemic circulation


Question 5

Intravenous heparin would be best used in which of the
following situations?

 A. In a patient with stable angina
 B. In a patient with a recent epidural hemorrhage
 C. In a patient with carotid artery stenosis
 D. In a patient with atrial fibrillation
 E. In a patient with myocardial infarction which was
treated by coronary angioplasty

Correct Answer: E. In a patient with myocardial infarction
which was treated by coronary angioplasty


Question 6

What are the two major classes of medications used to
manage angina pectoris?

 A. Vasoconstrictors and cardiac depressants
 B. Vasodilators and cardiac stimulants
 C. Inotropes and vasoconstrictors